Reply to nation et al

Clinical Infectious Diseases

Volumn 57, Issue 11, 2013, Pages 1657-1658

  Kassamali, Zahra ^a   Rotschafer, John C ^b   Jones, Ronald N ^c   Prince, Randall A ^d   Danziger, Larry H ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c JMI LABORATORIES   (United States)

^d UNIVERSITY OF HOUSTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLISTIMETHATE; COLISTIN; POLYMYXIN B; POLYMYXIN DERIVATIVE; POLYSORBATE 80;

BACTERICIDAL ACTIVITY; CHEMICAL STRUCTURE; HUMAN; LETTER; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; HUMANS; POLYMYXINS;

EID: 84887875780     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cit525     Document Type: Letter

References (14)

1. Nation RL, Li J, Turnidge J. The urgent need for clear and accurate information on the polymyxins. Clin Infect Dis. 2013; 57: 1656-7.
2. Kassamali Z, Rotschafer JC, Jones R.N., Prince RA, Danziger LH Polymyxins: wisdom does not always come with age. Clin Infect Dis 2013; 57: 877-83.
3. Lightbown JW, Bond JM, Grab B. The international standard for colistin. Bull World Health Organ 1973; 48: 65-74.
4. Lightbown JW, Bond JM, Grab B. The international reference preparation of colistin methane sulfonate. Bull World Health Organ 1973; 48: 75-80.
5. The 1st International Conference on Polymyxins. Prato, Italy, May 2-4, 2013. http://www.monash.edu/pharm/about/events/polymyxins.
6. Barnett M, Bushby SR, Wilkinson S. Sodium sulphomethyl derivatives of polymyxins. Br J Pharmacol Chemother 1964; 22: 552-74.
7. He H, Li JC, Nation R.L., et al Pharmacokinetics of four different brands of colistimethate and formed colistin in rats [Epub ahead of print]. J Antimicrob Chemother 2013; doi: 10.1093/jac/dkt207.
8. Albur MS, Bowker KE, Noel A.R., MacGowan AP Colistin MIC testing: the effect of different types of microtiter trays and surfactant tween80 in broth microdilution method. In: 52nd ICAAC, San Francisco, September 9-12, 2012.
9. Hindler JA, Humphries RM Colistin MIC variability by method for contemporary clinical isolates of multidrug-resistant gram-negative bacilli. J Clin Microbiol 2013; 51: 1678-84.
10. CLSI. Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Third Informational Supplement. CLSI document M100-S23. Wayne, PA: Clinical and Laboratory Standards Institute, 2013.
11. Garonzik SM, Li J, Thamlikitkul V., et al Population pharmacokinetics of colistin methanesulfonate and formed colistin in critically ill patients from a multicenter study provide dosing suggestions for various categories of patients. Antimicrob Agents Chemother 2011; 55: 3284-94.
12. Sader HS, Rhomberg PR, Flamm R.K., Jones RN Use of a surfactant (polysorbate-80) to improve MIC susceptibility testing results for polymyxin B and colistin. Diagn Microbiol Infect Dis 2012; 74: 412-4.
13. Lo-Ten-Foe JR, de Smet AM, Dierderen BM, Kluytmans JA, van Keulen PH. Comparative evaluation of the VITEK 2, disk diffusion, Etest, broth microdilution, and agar dilution susceptibility testing methods for colistin in clinical isolates, including heteroresistant Enterobacter cloacae and Acinetobacter baumannii strains. Antimicrob Agents Chemother 2007; 51: 3726-30.
14. van der Heijden IM, Levin AS, De Pedri EH, et al Comparison of disc diffusion, Etest and broth microdilution for testing susceptibility of carbapenem-resistant P. aeruginosa to polymy-xins. Ann Clin Microbiol Antimicrob 2007; 6: 8.